Detalhe da pesquisa
1.
A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and 'bad apple' effect on clinical trajectory.
J Hepatol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782118
2.
Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma.
BMC Cancer
; 23(1): 118, 2023 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737737
3.
A genomic enhancer signature associates with hepatocellular carcinoma prognosis.
JHEP Rep
; 5(6): 100715, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37168287
4.
Pan-cancer pervasive upregulation of 3' UTR splicing drives tumourigenesis.
Nat Cell Biol
; 24(6): 928-939, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618746
5.
Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study.
J Hepatocell Carcinoma
; 8: 1159-1167, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34589445
6.
Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast Cancer.
Front Oncol
; 11: 698551, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34336686